This announcement has been sent on behalf of our network supporters, the Harm Reduction Coalition:
African Americans and Hepatitis C
Thursday, July 25, 3:00 - 4:30 p.m. EDT
Hepatitis C is the most common chronic blood-borne infection in the United States and a leading cause of chronic liver disease, cirrhosis, and liver cancer. It is also a neglected health condition, with: African Americans and Blacks have a higher prevalence of chronic Hepatitis C infection compared with non-Hispanic white Americans and are twice as likely to have ever been infected with Hepatitis C.
This webinar will provide information on the impact of Hepatitis C on African Americans and strategies to address the viral hepatitis C epidemic in the African-American community.
The following will be discussed:
- Clinical issues in hepatitis C care and treatment for African Americans
- Role of the Affordale Care Act in addressing prevention, treatment and access to care for people living with viral hepatitis C
- Recommendations for increasing testing, linkage and prevention efforts as well as access to treatment and care
Moderator: Hadiyah Charles, M.A. -- Hepatitis Advocacy Manager, Harm Reduction Coalition
Christopher Bates, M.P.A. -- Senior Advisor to the Director Office of HIV/AIDS and Infectious Disease Policy
Marlene Taylor, P.A.-C. -- HIV/HCV Primary Care Provider Montefiore Medical Center, New York
Malinda Ellwood, J.D. -- Health Law and Policy Clinical Fellow, from Center for Health Law and Policy Innovation of Harvard Law School